UniSuper Management Pty Ltd boosted its position in Centene Co. (NYSE:CNC – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,433 shares of the company’s stock after acquiring an additional 1,412 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Centene were worth $3,116,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CNC. Capital Advisors Ltd. LLC increased its holdings in shares of Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares during the last quarter. Rialto Wealth Management LLC purchased a new position in Centene in the fourth quarter valued at approximately $30,000. OFI Invest Asset Management acquired a new stake in Centene during the fourth quarter worth approximately $33,000. SRS Capital Advisors Inc. lifted its position in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after buying an additional 267 shares during the last quarter. Finally, Riverview Trust Co grew its position in shares of Centene by 172.7% in the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock valued at $46,000 after buying an additional 480 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Stock Performance
NYSE CNC opened at $59.96 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $59.94 and its two-hundred day moving average is $62.73. The stock has a market capitalization of $29.74 billion, a price-to-earnings ratio of 9.61, a PEG ratio of 0.80 and a beta of 0.40. Centene Co. has a 12-month low of $55.03 and a 12-month high of $80.59.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the stock. Oppenheimer decreased their price objective on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, December 13th. Cantor Fitzgerald restated an “overweight” rating and set a $90.00 price target on shares of Centene in a research note on Wednesday, December 11th. Wells Fargo & Company reduced their price objective on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research note on Friday, February 14th. Argus cut shares of Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Finally, JPMorgan Chase & Co. reiterated an “overweight” rating and set a $75.00 price target (down previously from $80.00) on shares of Centene in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Centene presently has an average rating of “Moderate Buy” and an average price target of $79.92.
Check Out Our Latest Report on Centene
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 03/24 – 03/28
- What is the Nasdaq? Complete Overview with History
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Do S&P 500 Stocks Tell Investors About the Market?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.